Purpose One of the best indicators of adrenal gland dysfunction is the level of free cortisol measured in the 24-h urine (UFC) which faithfully reflects the level of biologically active serum cortisol not subjected to circadian variations. Liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS) is a sensitive, accurate and precise method recently available in routine laboratories that could remedy interference problems of immunoassays. Methods In this study, a literature reference range for UFC measured by LC-MS-MS was verified, and UFC values measured by LC-MS-MS and immunoassay were compared. Immunometric UFC measurement was performed by ACCESS COR-TISOL assay without preliminary extraction, using Beckman Coulter UniCel DxI 600 highly automated platform. Liquid chromatography-tandem mass spectrometry UFC measurement was performed by a home-made validated method using cortisol-D 4 as internal standard with preliminary deproteinization of urinary samples by centrifugal filter and injection on reverse-phase column. Cortisol was analyzed in positive ion mode with an ESI interface. Results The reference interval from literature (11-70 μg/day) was confirmed by results obtained for healthy study group. Comparison study of the two methods highlighted a constant and proportional systematic error with a general tendency to overestimate results for the in-use method. Conclusions In conclusion, the direct immunometric method overestimates UFC results with respect to liquid chromatography-tandem mass spectrometry which represents the reference method. The literature reference range 11-70 μg/day was confirmed and can be adopted by our lab that will shift all UFC tests performed in routine to the mass spectrometry-based method, satisfying clinicians' request.
Introduction
Adrenal glands-secreted hormones are responsible for a wide range of metabolic processes including carbohydrate, protein and fat conversion to glucose for energy, fluid and electrolyte balance and fat storage. Cortisol, the main human glucocorticoid, is secreted, with a circadian rhythm, by zona fasciculata of adrenal cortex in response to stress and low blood glucose level. The amount of UFC, free cortisol measured in the 24-h urine, faithfully reflects the level of biologically active serum cortisol not subjected to circadian variations. Analysis of UFC, along with serum cortisol and adrenocorticotropic hormone (ACTH), is the elective test for the diagnosis of Cushing's syndrome or disease caused by the autonomous and excessive production of cortisol [1, 2] .
Nowadays, high-throughput immunoassays are mainly used for laboratory UFC measurement, but it is known that these methods are affected by interferences due to antibody cross-reactivity with steroid metabolites and synthetic glucocorticoids [3, 4] . In particular, antibodies used in immunoassays are directed against the C-3 ketone group of cortisol, and compounds containing the same group may interfere with the antibody-antigen bond [3, 5] . At present, it is well known that mass spectrometry can overcome most of the above-mentioned criticisms. In particular, due to its characteristics of sensitivity, selectivity and accuracy, gas chromatography coupled to mass spectrometry (GC-MS) is less affected by problems of specificity and could be considered as the gold standard technique to measure steroid hormones [4, 6, 7] . However, while this technique is excellent to certify standard materials, its time-consuming sample preparation, as well as its low throughput, makes it as not suitable in a busy routine laboratory. On the contrary, liquid chromatography-tandem mass spectrometry (LC-MS-MS)-based methods are much less laborious, with shorter run times and, despite the high cost of instrumentation, they represent a good alternative to GC-MS in the quantification of small molecules such as steroid hormones [4] .
A simple LC-MS-MS method for UFC analysis suitable for routine purpose has recently been developed [5] . Using this sensitive, simple and free-from-interference method, the reference range 11-70 μg/day has been proposed.
The present study was planned (1) to verify UFC reference range in a specific population of healthy subjects using a method derived from one described in the literature; (2) to compare the results obtained by LC-MS-MS technique to those acquired by our in-use immunometric assay on patients' urine covering the whole measurable interval and the range of values clinically observable; (3) to find a possible alternative method to the immunometric one able to meet the needs of sensitivity and specificity of clinicians and, at the same time, be suitable for a high-throughput lab.
Methods

Urinary samples collection
UFC assay was performed on 24-h urine samples collected in a suitable container with no preservative, stored at 2-8 °C during collection. The total collection volume was registered. An aliquot of 10 mL for each sample was preserved in laboratory at − 80 °C until analysis.
To verify the literature reference range [5] , the urine of 31 apparently healthy volunteers was selected and UFC was measured by LC-MS-MS. Healthy volunteers, 12 males and 19 females, were recruited mainly from hospital staff, the age range was 19-66 years and previous measurements of UFC by immunoassay were found to be normal.
To compare the two methods, a total of 151 patients' urine samples (17-77 years, 42 males, 109 females) already dosed with Access Cortisol assay, and covering the whole measurable interval and the range of values clinically observable, were collected and analyzed by LC-MS-MS.
Informed consent was obtained both by volunteers and patients.
UFC measurement by LC-MS-MS
All the analyses were performed by an instrument layout consisting of an AB-Sciex API 4000 triple quadrupole mass spectrometer (Concord, ON, Canada), equipped with an Electrospray source (ESI) and coupled to an Agilent 1290 Infinity UHPLC system (Santa Clara, CA, USA), constituted by an autosampler outfitted with a Peltier tray, a binary pump, and a column oven. Chromatographic separation was performed by a Waters (Milford, MA, USA) Acquity UPLC HSS PFP 1.8 µm 100 × 2.1 mm column kept at 40 °C and protected by an Acquity UPLC HSS PFP 1.8 µm 5 × 2.1 mm precolumn. Cortisol was assayed with the isotope dilution technique using cortisol-D 4 (9,11,12,12-D 4 ) from SigmaAldrich (Saint Louis, MO, USA) as an internal standard. Mass spectrometer setting was strictly derived from a previously published method [8] [9] [10] . In practice, it operated in selected reaction monitoring (SRM) mode, by monitoring two transitions for both cortisol (F) and cortisol-D 4 (F-D 4 ), making use of optimized parameters to get the best possible performances. In particular, the SRM transitions were m/z 363 → 91 (F, qualifier), 363 → 121 (F, quantifier), 367 → 91 (F-D 4 , qualifier), 367 → 121 (F-D 4 , quantifier). Reversedphase UPLC operated in gradient mode, with water and methanol, both containing 0.1% of formic acid, as eluents at a flowrate of 400 µL/min. Sample preparation was performed according to the method described by Persichilli et al. [5] .
UFC measurement by immunometric assay
Urinary free cortisol measurements were performed using Access Cortisol assay, a competitive binding immunoenzymatic assay, on Beckman Coulter UniCel DxI 600 automated platforms (Beckman Coulter Diagnostics, Brea, CA, USA) according to the manufacturer's instructions. Samples may be analyzed directly or after a liquid-liquid extraction with ethyl acetate carried out before the test. The manufacturer supplied the following reference ranges with 95% confidence interval (CI): 21-111 μg/ day for the extraction method and 58-403 μg/day for the direct method. The analytical sensitivity of the method (0.4 μg/dL) and the total imprecision (7.9%, 6.0% and 6.4%) at concentrations near to 6, 24 and 38 μg/dL are reported from manufacturer for serum samples, since the method is also recommended for serum and plasma cortisol determination. Manufacturer also declared statistical data regarding the comparison of UFC values obtained, without extraction, by Access Cortisol assay with respect to UFC values obtained by a commercial equivalent assay (R = 0.968). Total imprecision monitored by our laboratory at concentrations near to 3, 12 and 28 μg/dL was, respectively, 5.50%, 6.59% and 6.72%. Finally, in our laboratory, urinary samples are directly analyzed and our reference range is 55-405 μg/day.
LC-MS-MS method validation
The method was validated in compliance with EMA guidelines [11] as regards linearity, lower limit of detection (LLOD), lower limit of quantitation (LLOQ), accuracy, precision and recovery. Method linearity was evaluated by 6 calibration curves built with 8 standard solutions at the following levels: 0.4096 (L1), 1.024 (L2), 2.560 (L3), 6 .400 (L4), 16 .00 (L5), 40.00 (L6), 100.0 (L7), and 250.0 ng/mL (L8). Instrumental LLOD and LLOQ were evaluated by injecting water solutions of cortisol at decreasing concentration levels up to signals 3 and 10 times the noise level for LLOD and LLOQ, respectively. Calculations were carried out by a specific Analyst tool. Intra-day accuracy and precision, expressed as accuracy % and relative standard deviation % (RSD %), respectively, were measured on human urine samples containing cortisol at known concentration levels: 1.0 ng/mL (C 1 , low level), and 8.5 ng/mL (C 2 , high level). Recovery (RE %) was evaluated by spiking a urine sample with cortisol-D 4 , acting as a surrogate analyte in the real matrix, at three different concentration levels: 3.2 (QC1), 8.0 (QC2), and 20 ng/mL (QC3). It was calculated comparing detected peak areas of cortisol-D 4 added before (A) and after (B) the ultra-filtration step by the formula RE (%) = A/B × 100.
Statistical and graphical analysis
Statistical analysis of results was carried out using the MedCalc statistical software for biomedical research (http:// www.medca lc.org). Method comparison included linear regression analysis and Pearson correlation coefficient determination, Passing-Bablok non-parametric regression analysis with a 95% CI [12, 13] and Bland-Altman analysis with 95% CI [14] .
Results
LC-MS-MS method validation
Calibration curve was linear within the concentration range 0.1640-250.0 ng/mL, with correlation coefficients always greater than 0.999. Slope and intercept, expressed as mean ± SD (n = 6), were m = 0.057 ± 0.011 and q = 0.003 ± 0.001, respectively. Instrumental LLOD and LLOQ were 0.1640 and 0.4096 ng/mL, respectively. These limit values confirmed a better sensitivity with respect to the method described by Persichilli et al. [5] , which reported 0.725 ng/mL and 2.54 ng/mL as a LLOD and LLOQ, respectively. Also intra-day accuracy and precision, that are shown in the Table 1 , were satisfactory, since they always were within ± 15% of the nominal value, as requested by the EMA guidelines [11] .
Recovery (RE %), expressed as a mean % of 10 replicate injections, was 83.8%, 83.5%, and 83.3% for QC1, QC2, and QC3, respectively. Actually, validation data were in satisfactory agreement with data from Persichilli et al. [5] .
Verification of reference range
To verify the reference range published in scientific articles, twenty samples from apparently healthy subjects covering the whole range may be used [15] . Reference range is accepted if the number of results outside the limits is ≤ 2, if the outsiders are three, twenty other samples have to be analyzed, if the outsides are four or more the analytical procedure has to be revised [15] . In this study, the urine of 31 healthy subjects was analyzed by LC-MS-MS for UFC evaluation. The reference interval for UFC measurement published in the literature [5] was verified as described above. Just two out of the 31 samples covering the whole range (11-70 μg/day) showed UFC values slightly out of the range (Fig. 1) ; thus, the range may be accepted and adopted by our laboratory.
Comparison between LC-MS-MS and immunometric assay
From linear regression analysis (y = 9.6241 + 0.1954x), the compared methods showed, as expected, no good linear relationship, with a Pearson correlation coefficient R = 0.8415 (Fig. 2) . Non-parametric Passing-Bablok regression (y = 7.658427 + 0.206367x) highlighted a constant and proportional systematic error as documented by value 0 not included in 95% CI for intercept, and value 1 not included in 95% CI for slope (Fig. 3) . Cusum test for linearity, only testing the applicability of the Passing-Bablok method, indicated no significant deviation from linearity (P = 0.89). Residual plot representing the distribution of differences around fitted regression line showed that residuals are randomly distributed above and below regression line over a wide range of values (Fig. 4) . Differences between the two measurements are clearly shown in Bland-Altman plot that defined a bias of 170.8 units and an agreement range from − 76.2 to 417.7 units (Fig. 5) . As expected, at clinical relevant range of values lower than 500 μg/day, the two methods failed to correlate with a marked overestimation of results by the immunometric assay. From Bland-Altman plot, a positive trend of differences, proportional to magnitude of measurements, was observed. The bias changed with concentration and differences were constant, with a slight enlargement of agreements limits correlating with concentration levels, confirming a systematic and proportional error with a general tendency to overestimate results for the in-use method.
Discussion
Adrenal glands produce hormones that help regulation of metabolism, immune system, blood pressure, response to stress and other main functions of organism. In particular, adrenal cortex produces hormones essential for life such as cortisol (metabolism regulation and stress response) and aldosterone (blood pressure control), while adrenal medulla produces nonessential hormones such as adrenaline (helps in stress reaction). The most common adrenal disorders are Addison's disease, Cushing's syndrome or disease, adrenal cancer, and congenital adrenal hyperplasia. These are very rare clinical conditions in which adrenal glands do not work as they should for a problem with adrenals themselves or for a defect in pituitary or hypothalamus.
One of the best indicators of adrenal glands dysfunction is UFC level reflecting biologically active serum cortisol not subjected to circadian variations. In fact, UFC is a sensitive test for the diagnosis of various types of adrenocortical dysfunctions, particularly useful for the screening of hypercortisolisms due to Cushing's syndrome. To confirm the clinical suspicion of this syndrome, in addition to measurement of excess UFC secretion, other abnormal responses to biochemical tests are needed such as the loss of normal hypothalamus-pituitary-adrenal axis feedback assessed by suppression test with dexamethasone, and modification of the normal circadian rhythm of cortisol secretion with high midnight serum values. Moreover, measuring both adrenal corticotrophic hormone (ACTH) and cortisol is useful in the differential diagnosis between these diseases as ACTH levels vary inversely with respect to cortisol levels [16, 17] . Also, the late-night salivary cortisol is a useful parameter for diagnosis of hypercortisolism, and its measurement in automated chemiluminescence and in LC-MS-MS with simple and rapid sample preparation is reliable in clinical practice [18] [19] [20] .
As known from literature, evaluation of cortisol levels in a complex matrix such as urine is a challenge for laboratories because of the presence of structurally similar steroids and metabolites that may interfere with antibodies used in immunometric assays, leading to falsely elevated cortisol values [21] . GC-MS procedures for specificity, precision and accuracy are generally accepted as reference methods for determination of steroid concentrations in biological fluids, but are not suitable for routine purposes for laboriousness, instrument high costs and low throughput [6, 7] . In recent years, LC-MS-MS has acquired an important role in clinical chemistry applications for its specificity, versatility and relative lower laboriousness in analysis [4, 22] .
The current routine procedure for UFC determination in our lab is the above-cited immunometric assay without pre-analytical extraction of samples, and the adopted reference range is 55-405 μg/day, near that recommended by manufacturer. However, clinicians often report that results are overestimated and do not correlate with patient's medical condition; so, we took into consideration to switch the test in LC-MS-MS using the previously described protocol.
In this paper, we describe the method used to verify the literature reference range for UFC and the comparison of UFC results obtained by LC-MS-MS with that obtained by our in-use immunometric assay. The reference interval from literature (11-70 μg/day) was confirmed by results obtained for healthy study group having only two UFC values slightly out of the range. From linear regression analysis, the compared methods showed no good linear relationship and nonparametric Passing-Bablok regression highlighted a constant and proportional systematic error. The Bland-Altman graphical analysis confirmed a systematic error with a general tendency to overestimate results for the in-use method.
It is not surprising that results obtained by immunoassay showed significant overestimation with a bias increasing proportionally with the UFC concentration [4, 23, 24] . In fact, routine determination of UFC is mainly performed by immunoassay based on modified serum cortisol assay methods that provide acceptable specificity for serum samples, but suffer from the high concentrations of interfering molecules present in the urine introducing positive bias for cross-reactivity with the antibodies of the assay [23, 24] . The interference may be due to ring-A reduced cortisol metabolites dihydrocortisol and tetrahydrocortisol, carbamazepine and synthetic corticosteroids which can affect immunoassay-based UFC results [4, 23, [25] [26] [27] [28] [29] .
To overcome this problem of immunoassays, more specific methods, based on liquid chromatography and gas chromatography mainly coupled to mass and tandem mass spectrometry detection, have been developed [30] [31] [32] . In particular, LC-MS-MS has several advantages such as high analytical specificity and sensitivity, lack of interference from autoantibodies and heterophilic immunoglobulins, and ability to measure simultaneously more than one analyte [33] [34] [35] . Nevertheless, this method also owns critical points like high instrumental costs, highly qualified dedicated staff, limited productivity, restricted number of CE-IVD reagents, accurate validation, standardization and harmonization, since a mass spectrometry method not necessarily represents a reference method [36] . For this reason, national and international scientific societies should implement strategies to achieve harmonization and standardization of methods based on mass spectrometry [37] .
In conclusion, a LC-MS-MS method to quantify UFC was tried out to reduce interference problems affecting immunometric assays and to satisfy clinicians' request for laboratory data really reflecting the status of patients. As expected, the direct immunometric method overestimates UFC results with respect to LC-MS-MS that represents the reference method. A reference range from literature was confirmed and can be adopted by our lab that is about to transfer all UFC tests performed in routine (about 900 examinations for year) to liquid chromatography-tandem mass spectrometry method.
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